GGrantIndex
← Leaderboards

Silke Paust

Jackson Laboratory

$15,804,854
Attributed
$16,173,728
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY201525
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,173,728 · 6

By mechanism

R01$14,944,765 · 4
R56$737,748 · 1
R21$491,215 · 1

Top collaborators

Most similar at Jackson Laboratory

Same institution · by research overlap

Others in their field

Top investigators on “In Vitro

Research focus

In VitroViralCellsMediatingB-LymphocytesResponseInfectionIn VivoNatural Killer CellsAntibodiesVaccinationVaccinatedImmunePreventImmunologic MemoryPhenotypeT-LymphocyteVaccinesHiv InfectionsImmune ResponseProteinsHiv VaccineAntigensFlow Cytometry

Grant awards (25)

Novel mechanisms regulating immunity to respiratory virus infection$1,742,128
R01 · FY2025 · AI · contact PI
How antigen exposure shapes the subsequent NK cell response to HIV$774,994
R01 · FY2025 · AI · contact PI
Novel mechanisms regulating immunity to respiratory virus infection$890,660
R01 · FY2024 · AI · contact PI
How antigen exposure shapes the subsequent NK cell response to HIV$810,003
R01 · FY2024 · AI · contact PI
Novel mechanisms regulating immunity to respiratory virus infection$913,500
R01 · FY2023 · AI · contact PI
How antigen exposure shapes the subsequent NK cell response to HIV$438,845
R01 · FY2023 · AI · contact PI
How antigen exposure shapes the subsequent NK cell response to HIV$418,276
R01 · FY2023 · AI · contact PI
Control of HIV-induced MDSC expansion and immunosuppression by cytotoxic lymphocytes$189,520
R21 · FY2023 · AI · contact PI
Control of HIV-induced MDSC expansion and immunosuppression by cytotoxic lymphocytes$35,445
R21 · FY2023 · AI · contact PI
Novel mechanisms regulating immunity to respiratory virus infection$1
R01 · FY2023 · AI · contact PI
How antigen exposure shapes the subsequent NK cell response to HIV$863,699
R01 · FY2022 · AI · contact PI
Control of HIV-induced MDSC expansion and immunosuppression by cytotoxic lymphocytes$266,250
R21 · FY2022 · AI · contact PI
How antigen exposure shapes the subsequent NK cell response to HIV$887,484
R01 · FY2021 · AI · contact PI
Mechanisms of Protection of Universal Therapeutic Antibodies to Influenza A$773,720
R01 · FY2021 · AI · contact PI
Mechanisms of Protection of Universal Therapeutic Antibodies to Influenza A$817,703
R01 · FY2020 · AI · contact PI
Mechanisms of Protection of Universal Therapeutic Antibodies to Influenza A$898,865
R01 · FY2019 · AI · contact PI
Harnessing NK Memory to Protect Against HIV Infection$766,092
R01 · FY2019 · AI · contact PI
Mechanisms Of Protection of Universal Therapeutic Antibodies To Influenza A$767,642
R01 · FY2018 · AI · contact PI
Harnessing NK Memory To Protect Against HIV Infection$608,682
R01 · FY2018 · AI · contact PI
Mechanisms Of Protection of Universal Therapeutic Antibodies To Influenza A$793,063
R01 · FY2017 · AI · contact PI
Harnessing NK Memory To Protect Against HIV Infection$558,874
R01 · FY2017 · AI · contact PI
Harnessing NK Memory To Protect Against HIV Infection$58,605
R01 · FY2017 · AI · contact PI
Shaping Natural Killer repertoires and HIV responsiveness via antigen exposure$737,748
R56 · FY2016 · AI · contact PI
Harnessing NK Memory To Protect Against HIV Infection$568,945
R01 · FY2016 · AI · contact PI
Harnessing NK Memory To Protect Against HIV Infection$592,984
R01 · FY2015 · AI · contact PI